Last update 30 Nov 2024
Recombinant human anti-RANKL momoclonal antibody(Hualan Genetic Engineering Co Ltd)
Last update 30 Nov 2024
Overview
Basic Info
Drug Type Monoclonal antibody |
Synonyms HL 05, HL-05, HL05 |
Target |
Mechanism RANKL inhibitors(Tumor necrosis factor ligand superfamily member 11 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with Recombinant human anti-RANKL momoclonal antibody(Hualan Genetic Engineering Co Ltd)一项随机、双盲、平行对照比较重组抗RANKL全人源单克隆抗体注射液（HL05）和地舒单抗注射液（Xgeva®）在实体瘤骨转移患者中有效性、安全性和免疫原性的Ⅲ期临床试验
[Translation] A randomized, double-blind, parallel-controlled phase III clinical trial comparing the efficacy, safety, and immunogenicity of a recombinant anti-RANKL fully human monoclonal antibody injection (HL05) and denosumab injection (Xgeva®) in patients with bone metastases from solid tumors
随机、双盲、单剂量、平行比较HL05与Xgeva在健康男性志愿者中药代动力学相似性和安全性的Ⅰ期临床研究
[Translation] A randomized, double-blind, single-dose, parallel phase I clinical study comparing the pharmacokinetic similarity and safety of HL05 and Xgeva in healthy male volunteers
100 Clinical Results associated with Recombinant human anti-RANKL momoclonal antibody(Hualan Genetic Engineering Co Ltd)
Login to view more data
100 Translational Medicine associated with Recombinant human anti-RANKL momoclonal antibody(Hualan Genetic Engineering Co Ltd)
Login to view more data
100 Patents (Medical) associated with Recombinant human anti-RANKL momoclonal antibody(Hualan Genetic Engineering Co Ltd)
Login to view more data
100 Deals associated with Recombinant human anti-RANKL momoclonal antibody(Hualan Genetic Engineering Co Ltd)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Bone metastases | Phase 3 | CN | 16 Feb 2023 | |
| Solid tumor | Phase 3 | CN | 16 Feb 2023 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free